Pulse Biosciences, Inc. developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced first patient enrollments in the multi-center first-in-human feasibility study of the Company’s nPulse™ Vybrance™ Percutaneous Electrode System for treatment of T1N0M0 papillary thyroid microcarcinoma (PTM), a small, slow-growing, and most common form of thyroid cancer. The initial proce

The WHO Foundation today announced an expanded collaboration with Novo Nordisk to support global efforts to strengthen health systems against the rising burden of cardio-renal-metabolic diseases, including obesity and diabetes. Novo Nordisk has committed a total of USD 7.9 million to support this effort, with an initial gift of USD 2.9 million in 2024 followed by an additional USD 5 million in December 2025. The contribution will enable the WHO Foundation to support WHO

Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that it has submitted a De Novo 510(k) application to the U.S. Food and Drug Administration (FDA) seeking marketing clearance for its Breast Cancer Locator (BCLTM) System. A medical device can be designated for the De Novo pathway when it offers novel technology with a reasonable assurance of safety and effectiveness for the intended use, and there is no legally mar

HeartBeam, Inc, a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerate the joint development and validation of next-generation AI-ECG algorithms. The collaboration will leverage HeartBeam’s patented ECG platform, which captures the heart’s electrical activity from 3 non-coplanar dimensions. The partnership marks a s

Royal Philips a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous, actionable understanding of the patient. Health systems are under

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts, which include the Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans are expected to become effective on

Health systems face ongoing staffing shortages and rising demand for advanced imaging, placing additional pressure on MR departments. At the same time, cardiac MR (CMR) plays an important role in assessing heart structure and function.  Cardiac MR exams traditionally require experienced operators to navigate complex scan planning, breath-hold coordination, and patient-specific variations. By integrating AI directly into the planning workflow, SmartHeart automates these steps in

Smith+Nephew the global medical technology company, today announces it will feature handheld robotics and digital solutions for hip, knee and shoulder in addition to innovative trauma and extremities products during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in New Orleans this week. Some of the company’s latest Orthopaedics advancements and highlighted technologies include: Handheld Robotics: Optimizing and Personalizing Surgery

WellSky, a global health and community care technology and services company, today announced the expansion of artificial intelligence (AI) capabilities within its next‑generation WellSky CarePort Referral Intake solution. The enhancement uses AI-driven document extraction and clinical summarization to consolidate referrals arriving from multiple channels into a single, actionable worklist in one platform, helping providers evaluate and admit patients faster and more efficiently. B

At the close of Heart Month, Edwards Lifesciences underscored its leadership in structural heart innovation, advancing care through deep expertise and strong partnerships so people with structural heart disease can live longer, healthier lives. As part of this commitment, Edwards announced the impact and renewed vision for Every Heartbeat Matters, its signature global health initiative, to help 2 million more patients facing barriers worldwide access lifesaving structural heart treatment by t